The role of polio-vaccine in pleural mesothelioma--an epidemiological observation

Coll Antropol. 2008 Jun;32(2):479-83.

Abstract

From the Croatian Cancer Registry (period 1991-1997) 194 malignant pleural mesothelioma patients were collected. According to participation in polio vaccination mass campaign in 1961 that covered the entire Croatian population aged 3 months to 20 years, mesothelioma patients were divided in vaccinated (N=58), and non-vaccinated (N=136) subjects. Significantly higher percentage of those with a history of occupational exposure to asbestos was found in vaccinated (79%) compared to non-vaccinated group (63%). This is the opposite to what would be expected if potential SV40 contamination of polio vaccine used had a causative role in the development of the tumour. On the other hand, shorter latency period reflected by very high percentage of 45-year-old or younger mesothelioma patients in vaccinated group (15 out of 58), with all of them having a history of occupational asbestos exposure, raises a question for a possible enhancing effect of the vaccine used to asbestos exposure, if it was contaminated with SV40.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Asbestos / adverse effects
  • Drug Contamination*
  • Female
  • Humans
  • Male
  • Mesothelioma / etiology
  • Mesothelioma / virology*
  • Middle Aged
  • Occupational Exposure / adverse effects
  • Pleural Neoplasms / etiology
  • Pleural Neoplasms / virology*
  • Poliovirus Vaccines / adverse effects*
  • Simian virus 40 / isolation & purification*

Substances

  • Poliovirus Vaccines
  • Asbestos